Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo

Published:2018-02-26 Issue:1 Volume:37 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Yao Shu,Li Li,Su Xuan-tao,Wang Kai,Lu Zai-jun,Yuan Cun-zhong,Feng Jin-bo,Yan Shi,Kong Bei-hua,Song Kun

Funder

National Natural Science Foundation of China

Fundamental Research Funds of Shandong University

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-018-0700-z.pdf

Reference34 articles.

1. Brett MR, Jennifer BP, Thomas AS. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2016;0084:9–32.

2. Li Z, Sun LP, Lu ZJ, Su XT, Yang QF, Qu X, et al. Enhanced effect of photodynamic therapy in ovarian cancer using a nanoparticle drug delivery system. Int J Oncol. 2015;47:1070–6.

3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.

4. Huang L, Cronin KA, Johnson KA, Mariotto AB, Feuer EJ. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer? Cancer. 2008;112:2289–300.

5. Keith LK, Lavakumar K, Purushottam L, Claudia P. Targeted immune therapy of ovarian cancer. Cancer Metastasis Rev. 2015;34:53–74.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies;ACS Omega;2024-08-23

2. Recent advances in protein-based nanoparticles and their applications in the delivery of bioactive compounds;International Journal of Food Properties;2023-09-28

3. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors;Current Medicinal Chemistry;2023-06

4. New trends in diagnosing and treating ovarian cancer using nanotechnology;Frontiers in Bioengineering and Biotechnology;2023-04-04

5. Nucleus-Targeting Manganese Dioxide Nanoparticles Coated with the Human Umbilical Cord Mesenchymal Stem Cell Membrane for Cancer Cell Therapy;ACS Applied Materials & Interfaces;2023-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3